Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/25/14  and contains information from public web pages.

Dr. Alpdogan Kantarci

Wrong Dr. Alpdogan Kantarci?

Adjunct Associate Professor

Boston University Henry Goldman School of Dental Medicine
 
Background

Employment History

  • Adjunct Faculty Position
    Boston University
  • Assistant Professor
    Henry Goldman School of Medicine
  • Faculty Member
    Harvard University

Board Memberships and Affiliations

Education

  • DDS
  • PhD
  • clinical and PhD studies
    Istanbul University at the Department of Periodontology
  • doctorate
  • MSc , Applied Oral Sciences
7 Total References
Web References
Alpdogan Kantarci, DDS, PhD, ...
forsyth.org, 25 Mar 2014 [cached]
Alpdogan Kantarci, DDS, PhD, CAGS, Diplomate, American Board of Periodontology
...
Dr. Kantarci is an Associate Member of the Staff at the Forsyth Institute in Cambridge, MA, USA, works as a Faculty Member at Harvard University School of Dental Medicine, and serves as an Adjunct Associate Professor at Boston University Henry Goldman School of Dental Medicine. He has started his career as dentist after graduating from Istanbul University in 1991. He completed his clinical and PhD studies at Istanbul University at the Department of Periodontology joining the faculty. He moved to the USA in 1999 as a postdoctoral fellow at Boston University. Upon completing his postdoctoral studies in 2002, he has started clinical periodontology training at Boston University. After graduating, he was appointed as an Assistant Professor in 2004 at the Henry Goldman School of Medicine. He was promoted to the Associate Professorship in 2009. In 2010, he joined the Forsyth Institute maintaining his adjunct faculty position at Boston University.
During his academic career, Dr. Kantarci has been actively involved in training, education and patient care. He has mentored more than 30 PhD, doctorate, and Master's theses; directed and taught in several graduate and postgraduate clinical and didactic dentistry courses. He serves in the editorial board and as a reviewer of 15 dental and medical scientific journals. He is the recipient of numerous federal, international and industry-supported research grants and holds several patents. He has published more than 85 articles in peer-reviewed scientific journals, wrote book chapters, and has presented more than 170 oral talks and posters in dental and medical congresses.
His passion is the translation of scientific knowledge to patient care. Through this, Dr. Kantarci believes that health can be improved, lost tissues due to disease can be restored and success can be maintained over long-term. He is an active cyclist, loves traveling and exploring.
Alpdogan Kantarci, DDS, MSc, ...
forsyth.org, 8 Dec 2013 [cached]
Alpdogan Kantarci, DDS, MSc, PhD Applied Oral Sciences The Forsyth Institute: Scientists & Research - Alpdogan Kantarci, DDS, MSc, PhD
...
Alpdogan Kantarci
Associate Member of the Staff Department of Applied Oral Health Sciences
...
Pubmed Search - Alpdogan Kantarci PubMed search
(Alpdogan Kantarci, DDS, MSc, PhD)
A Diplomate of the American Board of Periodontology and the current President of the Periodontal Research Group of the International Association for Dental Research, Dr. Kantarci focuses on improving periodontal and systemic health through the integration of clinical and laboratory research. His main interest is the characterization of inflammatory pathways of periodontal disease and utilization of this knowledge for development of novel therapeutic strategies to restore the homeostasis of periodontium.
Inflammation and resolution of inflammatory pathways in periodontal disease and diabetes
Research in the Kantarci lab focuses on investigation of the molecular mechanisms and resolution pathways of oral inflammation in patients with periodontitis, diabetes, and HIV infection. Inflammation research is the center of Dr. Kantarci's studies and he has extensive experience in using experimental animal models for these diseases. Specifically, Dr. Kantarci focuses on the signal transduction mediated by lipids and various proteins in neutrophils and monocytes and their interaction with other cells of the oral cavity. He has developed several in vitro assays and applications of high-throughput analysis (e.g. xMAP Multiplexing) to translational clinical research. To this end, he is testing the inflammatory mediator content in various milieu such as gingival crevicular fluid, saliva and serum. Recently, he has been focused on various the impact of hypoxia on cell functions. Inflammation-mediated hypoxia is an important mechanism in various pathological processes such as periodontitis (and at large in inflammatory diseases).
Mechanism of gingival fibrosis
Dr. Kantarci has been working on the clinical characterization and the mechanism of fibrotic changes in gingival tissues as a side effect of various medications. This is an important phenomenon caused by cyclosporin-A (an immunosuppressant widely used in solid organ transplants), phenytoin (an anti-epileptic medication), and various calcium channel blockers used to control hypertension. Common to all these medications, significant and debilitating fibrotic enlargements of the gingival tissues pose a major problem to patients and affect the quality of life. In collaboration with Dr. Philip Trackman, Dr. Kantarci has identified multiple mechanisms for the fibrotic enlargements of the gingival tissues.
...
Dr. Kantarci has been leading a series of studies on the osteoblast and osteoclast activity in alveolar bone in response to orthodontic tooth movement with or without various methods to enhance the speed of the movement and the bone turnover. This line of research focuses on techniques to improve the outcomes for orthodontic patients and speed recovery time. Recent work from Dr. Kantarci's laboratory has shown that tooth movement was significantly accelerated-a 3 to 4-fold increase-over traditional orthodontic treatment.
...
Kantarci A, Augustijn P, Firatli E, Sheff MC, Hasturk H,Graves DT, Trackman PC. 2007. Apoptosis in gingival overgrowth tissues. J. Dent. Res. 86(9):888-892.
The Forsyth Institute: Scientists & Research - Alpdogan Kantarci, DDS, MSc, PhD
www.forsyth.org, 29 June 2013 [cached]
Alpdogan Kantarci, DDS, MSc, PhD Applied Oral Sciences | Alp Kantarci, D.D.S., Msc.,Ph.D. The Forsyth Institute: Scientists & Research - Alpdogan Kantarci, DDS, MSc, PhD
...
Alpdogan Kantarci
Associate Member of the Staff Department of Applied Oral Health Sciences
...
Pubmed Search - Alpdogan Kantarci PubMed search
(Alpdogan Kantarci, DDS, MSc, PhD)
A Diplomate of the American Board of Periodontology and the current President of the Periodontal Research Group of the International Association for Dental Research, Dr. Kantarci focuses on improving periodontal and systemic health through the integration of clinical and laboratory research. His main interest is the characterization of inflammatory pathways of periodontal disease and utilization of this knowledge for development of novel therapeutic strategies to restore the homeostasis of periodontium.
Inflammation and resolution of inflammatory pathways in periodontal disease and diabetes
Research in the Kantarci lab focuses on investigation of the molecular mechanisms and resolution pathways of oral inflammation in patients with periodontitis, diabetes, and HIV infection. Inflammation research is the center of Dr. Kantarci's studies and he has extensive experience in using experimental animal models for these diseases. Specifically, Dr. Kantarci focuses on the signal transduction mediated by lipids and various proteins in neutrophils and monocytes and their interaction with other cells of the oral cavity. He has developed several in vitro assays and applications of high-throughput analysis (e.g. xMAP Multiplexing) to translational clinical research. To this end, he is testing the inflammatory mediator content in various milieu such as gingival crevicular fluid, saliva and serum. Recently, he has been focused on various the impact of hypoxia on cell functions. Inflammation-mediated hypoxia is an important mechanism in various pathological processes such as periodontitis (and at large in inflammatory diseases).
Mechanism of gingival fibrosis
Dr. Kantarci has been working on the clinical characterization and the mechanism of fibrotic changes in gingival tissues as a side effect of various medications. This is an important phenomenon caused by cyclosporin-A (an immunosuppressant widely used in solid organ transplants), phenytoin (an anti-epileptic medication), and various calcium channel blockers used to control hypertension. Common to all these medications, significant and debilitating fibrotic enlargements of the gingival tissues pose a major problem to patients and affect the quality of life. In collaboration with Dr. Philip Trackman, Dr. Kantarci has identified multiple mechanisms for the fibrotic enlargements of the gingival tissues.
...
Dr. Kantarci has been leading a series of studies on the osteoblast and osteoclast activity in alveolar bone in response to orthodontic tooth movement with or without various methods to enhance the speed of the movement and the bone turnover. This line of research focuses on techniques to improve the outcomes for orthodontic patients and speed recovery time. Recent work from Dr. Kantarci's laboratory has shown that tooth movement was significantly accelerated-a 3 to 4-fold increase-over traditional orthodontic treatment.
...
Kantarci A, Augustijn P, Firatli E, Sheff MC, Hasturk H,Graves DT, Trackman PC. 2007. Apoptosis in gingival overgrowth tissues. J. Dent. Res. 86(9):888-892.
Diamond Dental Discussions
mydiamonddental.com [cached]
The problem is that humans (and many mammals) do not have the means to metabolize these lipids and cannot produce them in sufficient quantities," said Alpdogan Kantarci, DDS, PhD, of the Forsyth Institute and co-author on several key studies examining the issue.
...
7021-7029), the researchers even found that omega-3 benefits appeared to extend to the bones, Dr. Kantarci said.
"We have shown that such an approach cannot only reverse the inflammatory process, but also can help in regenerating the lost bone and hard tissues, so there is a lot of exciting potential," he said.
...
"This does not mean that the antibiotics will be replaced soon, since many infections will most probably still require elimination or decrease of bacterial load," Dr. Kantarci said.
Associate Professor Dr. Alpdogan ...
www.cn-medicine.com [cached]
Associate Professor Dr. Alpdogan Kantarci traveled to Barcelona, Spain in mid-July to attend the International Association for Dental Research (IADR) General Session.
...
The oral presentation was based on Dr. Kantarci's research, which is sponsored by Biolux Research Ltd., and examines the effects of non-invasive photobiomodulation on tooth movement in an animal model.
Read more...
Tags: Alpdogan Kantarci, Kantarci
Other People with the name "Kantarci":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304